Analyst firms · BofA Securities · GDRX
BofA Securities GDRX price target and rating history
GoodRx Holdings Inc. (GDRX) · Technology
BofA Securities rates GoodRx Holdings Inc. (GDRX) Underperform with a $4.50 price target, as of its latest action on Jan 2, 2024. It has published 3 rating actions on GDRX since March 2022, including 0 upgrades and 1 downgrade.
- Current rating
- Underperform
- Price target
- $4.50
- Median target, all firms
- Too few
- Actions on GDRX
- 3
BofA Securities price target on GDRX
Every BofA Securities rating on GDRX
- Jan 2, 2024
- Jun 6, 2022
- Mar 1, 2022
How other firms rate GDRX
Each firm's latest rating and stated target in the last 12 months.
Questions about BofA Securities and GDRX
- What is BofA Securities's price target for GDRX?
- BofA Securities's latest stated price target for GoodRx Holdings Inc. (GDRX) is $4.50, from its action on Jan 2, 2024.
- What is BofA Securities's rating on GDRX?
- BofA Securities rates GDRX Underperform, a bearish rating, as of Jan 2, 2024.
- When did BofA Securities last change its view on GDRX?
- On Jan 2, 2024, BofA Securities downgrades to Underperform from Buy, price target $8 to $4.50.
More GDRX rating histories
- Barclays5
- Raymond James6
- RBC Capital Markets3
- J.P. Morgan3
- Leerink Partners4
- TD Cowen3
- Goldman Sachs3
- Credit Suisse3
- Morgan Stanley3
All BofA Securities ratingsGDRX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.